Tuesday, January 26, 2021  | 11 Jamadilakhir, 1442
Samaa TV
Facebook Twitter Youtube
HOME > Health

Karachi’s JPMC allowed to use plasma for passive immunisation therapy

The convalescent plasma helps fight coronavirus through antibodies

SAMAA | - Posted: May 6, 2020 | Last Updated: 9 months ago
SAMAA |
Posted: May 6, 2020 | Last Updated: 9 months ago
Karachi’s JPMC allowed to use plasma for passive immunisation therapy

Photo: AFP

The Sindh government allowed on Wednesday the Jinnah Postgraduate Medical Centre in Karachi to make experimental use of COVID-19 convalescent plasma for passive immunization therapy, its health department said in a statement.

Convalescent plasma is the blood plasma donated by patients who have recovered from COVID-19. It contains antibodies that can fight the virus. Clinical trials of this therapy have also begun in different parts of the world.

The Drug Regulatory Authority of Pakistan approved clinical trials for plasma therapy and local manufacturing of the active ingredient of drug chloroquine for the treatment of COVID-19 on April 9.

The JPMC was granted permission on the terms that the process will be supervised by hospital staff which includes a physician or infectious disease specialist, ICU specialist, consultant hematologist and a representative of the Sindh Blood Transfusion Authority.

The provincial government previously allowed the use of therapy to the Dr Ruth Pfau Civil Hospital in Karachi, Liaquat University Hospital in Hyderabad and the National Institute of Blood Diseases in Karachi.

FaceBook WhatsApp
 
HOME  
 
 
RELATED STORIES

Tell us what you think:

Your email address will not be published.

FaceBook WhatsApp
 

 
 
coronavirus vaccine pakistan news today, coronavirus vaccine trials in pakistan, bcg vaccine pakistan coronavirus, astrazeneca covid vaccine approval, astrazeneca vaccine update, astrazeneca vaccine approval, astrazeneca covid vaccine efficacy, astrazeneca vaccine type, astrazeneca vaccine vs pfizer, astrazeneca vaccine usa, astrazeneca vaccine india, oxford university-astrazeneca covid-19 vaccine status, sinopharm vs pfizer, sinovac vaccine efficacy, sinovac vs pfizer vaccine
 

MOST READ
MOST READ
Bengali ‘Pakistanis’ bring home Russian gold
 
 
 
 
 
About Us   |   Anchor Profiles   |   Online Advertising   |   Contact Us   |   Feedback   |   Apps   |   FAQs   |   Authors   |   Comment Policy
Facebook   |   Twitter   |   Instagram   |   YouTube   |   WhatsApp